Wordt geladen...
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives
Gastroenteropancreatic neuroendocrine tumours (GEP NETs) are rare tumours that present many clinical features. They secrete peptides and neuroamines that cause distinct clinical syndromes, including carcinoid syndrome. However, many are clinically silent until late presentation with mass effects. In...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2845555/ https://ncbi.nlm.nih.gov/pubmed/20196864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-29-19 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|